1. Home
  2. ATEC vs RARE Comparison

ATEC vs RARE Comparison

Compare ATEC & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEC
  • RARE
  • Stock Information
  • Founded
  • ATEC 1990
  • RARE 2010
  • Country
  • ATEC United States
  • RARE United States
  • Employees
  • ATEC N/A
  • RARE N/A
  • Industry
  • ATEC Medical/Dental Instruments
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATEC Health Care
  • RARE Health Care
  • Exchange
  • ATEC Nasdaq
  • RARE Nasdaq
  • Market Cap
  • ATEC 2.3B
  • RARE 2.6B
  • IPO Year
  • ATEC 2006
  • RARE 2014
  • Fundamental
  • Price
  • ATEC $15.26
  • RARE $30.31
  • Analyst Decision
  • ATEC Strong Buy
  • RARE Strong Buy
  • Analyst Count
  • ATEC 7
  • RARE 14
  • Target Price
  • ATEC $17.29
  • RARE $86.64
  • AVG Volume (30 Days)
  • ATEC 2.0M
  • RARE 1.4M
  • Earning Date
  • ATEC 10-29-2025
  • RARE 11-04-2025
  • Dividend Yield
  • ATEC N/A
  • RARE N/A
  • EPS Growth
  • ATEC N/A
  • RARE N/A
  • EPS
  • ATEC N/A
  • RARE N/A
  • Revenue
  • ATEC $682,236,000.00
  • RARE $610,159,000.00
  • Revenue This Year
  • ATEC $23.76
  • RARE $19.72
  • Revenue Next Year
  • ATEC $18.26
  • RARE $23.29
  • P/E Ratio
  • ATEC N/A
  • RARE N/A
  • Revenue Growth
  • ATEC 26.27
  • RARE 26.77
  • 52 Week Low
  • ATEC $4.88
  • RARE $25.81
  • 52 Week High
  • ATEC $16.70
  • RARE $60.37
  • Technical
  • Relative Strength Index (RSI)
  • ATEC 49.88
  • RARE 49.05
  • Support Level
  • ATEC $15.21
  • RARE $31.22
  • Resistance Level
  • ATEC $16.70
  • RARE $31.80
  • Average True Range (ATR)
  • ATEC 0.52
  • RARE 0.93
  • MACD
  • ATEC -0.24
  • RARE 0.07
  • Stochastic Oscillator
  • ATEC 10.00
  • RARE 35.88

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: